Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,590.00
-110.00 (-1.93%)
Jan 5, 2026, 2:10 PM KST

Kyongbo Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
136,269148,701200,579239,069256,999390,877
Upgrade
Market Cap Growth
-22.76%-25.86%-16.10%-6.98%-34.25%97.94%
Upgrade
Enterprise Value
255,750236,571278,339290,819317,767437,346
Upgrade
Last Close Price
5700.006220.008333.629873.4610553.9415976.08
Upgrade
PE Ratio
57.6632.0567.44391.54-41.56
Upgrade
PS Ratio
0.540.620.931.221.511.82
Upgrade
PB Ratio
0.941.021.391.661.762.51
Upgrade
P/TBV Ratio
0.961.051.431.701.812.56
Upgrade
P/FCF Ratio
----556.6044.73
Upgrade
P/OCF Ratio
19.73997.2141.4123.6114.3018.80
Upgrade
EV/Sales Ratio
1.010.991.291.481.862.03
Upgrade
EV/EBITDA Ratio
11.4710.3516.1421.8251.8220.58
Upgrade
EV/EBIT Ratio
27.1022.6350.20208.82-50.49
Upgrade
EV/FCF Ratio
-8.55---688.2250.05
Upgrade
Debt / Equity Ratio
0.850.630.530.450.390.41
Upgrade
Debt / EBITDA Ratio
6.584.004.404.849.232.98
Upgrade
Debt / FCF Ratio
----122.557.24
Upgrade
Asset Turnover
0.850.870.850.820.700.88
Upgrade
Inventory Turnover
1.781.942.402.652.272.63
Upgrade
Quick Ratio
0.390.440.530.610.590.79
Upgrade
Current Ratio
0.951.151.151.221.251.47
Upgrade
Return on Equity (ROE)
1.63%3.19%2.07%0.42%-4.97%6.16%
Upgrade
Return on Assets (ROA)
1.25%2.38%1.37%0.36%-1.69%2.21%
Upgrade
Return on Capital (ROIC)
1.48%2.85%1.62%0.42%-1.96%2.55%
Upgrade
Return on Capital Employed (ROCE)
4.00%6.90%3.70%1.00%-4.50%5.40%
Upgrade
Earnings Yield
1.74%3.12%1.48%0.26%-2.92%2.41%
Upgrade
FCF Yield
-21.96%-8.44%-2.42%-1.15%0.18%2.24%
Upgrade
Payout Ratio
50.51%25.77%40.19%195.77%-25.42%
Upgrade
Buyback Yield / Dilution
-0.32%0.34%-2.14%1.62%0.25%-0.10%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.